Fabhalta $0 Co-Pay Plus Program
Funded
About
The Fabhalta $0 Co-Pay Plus Program is designed to provide substantial financial assistance to eligible patients, making the drug Fabhalta more accessible. This program allows patients with private insurance to potentially pay as little as $0 for their Fabhalta prescription, with a maximum annual benefit of $20,000 for prescription costs and up to $1,000 for qualifying vaccination expenses. The Fabhalta $0 Co-Pay Plus Program is not only a powerful tool for easing the financial burden of treatment but also a supportive resource for the eligible patients in the United States, Puerto Rico, and selected territories.
Insurance requirements: Commercially insured
Enrollment Forms
Enrollment Form
Benefits
•$20000 annual maximum benefit
Program Requirements
•Valid only for residents in the US and Puerto Rico
•Must be 18 years of age or older
•Enrollment Required: Yes
•Coverage Required: No
•Needs Based: No
•Activation Required: No
Program Details
•Eligible commercially insured patients may pay $0 per prescription
•Maximum benefit of up to $20,000 in annual copay benefits for the cost of FABHALTA and up to $1,000 for qualifying vaccination costs (excluding administrative fees)
•Patient is responsible for any costs once limit is reached in a calendar year
•Patient may enroll online or HCP may submit completed start form via fax to 8774432242
•For assistance or additional information, call 8339932242
Enrollment Forms
Enrollment Form